Pneumococcal Testing Market
Market Insights on Pneumococcal Testing covering sales outlook, demand forecast & up-to-date key trends
Pneumococcal Testing Market by Product (Consumables and Analyzers), by Method (Immunodiagnostics, Molecular Diagnostic and Point of Care Testing) & Region for 2022-2030
Pneumococcal Testing Market Snapshot
[287 Pages Report] The global Pneumococcal Testing Market is valued at US$ 1.6 Bn in 2022 and is expected to reach US$ 3.6 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey.
Pneumococcal Testing Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2022 |
USD 1.6 Bn |
|
Market Value 2030 |
USD 3.6 Bn |
|
CAGR 2022-2030 |
11.2% |
|
Key Players |
The key players are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Abbott Laboratories, F-Hoffmann la Roche Ltd, Hologic, Inc., bioMerieux, Bio-Rad Laboratories, Inc., Meridian Biosciences, Quest Diagnostics and Quidel. |
|
Share of Top 5 Countries |
62.1% |
The pneumococcal testing market is anticipated to observe robust growth due to the development in point-of-care (POC) testing products and growth of advanced nucleic acid detection tests. Moreover, rising cases of pneumonia, growing demand for pneumococcal testing and advancement in point-of-care testing for community-acquired pneumonia are responsible for the development of the pneumococcal testing market.
Pneumococcal testing market holds nearly 3.1% market value share of the US$ 45 Bn diagnostics market in 2021. In addition, the rise in adoption of molecular diagnostic testing in the emerging economies are anticipated to offer new paths for the development of pneumonia testing market in the coming years.
Driven by this, sales of pneumococcal testing are expected to rise at 11.2% CAGR through 2030.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
11.08% |
|
H1, 2022 Projected |
11.21% |
|
H1, 2022 Outlook |
11.11% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(+) 3 ↑ |
The comparative analysis and market growth rate of global pneumococcal testing market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 10 BPS.
As per the FMI Analysis, the global pneumococcal testing market will observe an increased change in the Basis Point Share (BPS) by nearly 03 units in H1- 2022 (O) as compared to H1-2021.
This was majorly due to the prevalence of high pneumococcal carriage rate among adults and children, adoption of multi-locus sequence analysis (MLSA) for pathogen identification, and high diagnostic yield of pneumococcal testing, promoting this rise in the BPS value.
The key factors boosting the demand for pneumococcal testing are the development of novel biomarkers for rapid disease testing, and the structuring of detection methods for pneumococcal antigens.
Additionally, introduction of pneumococcal conjugate vaccines for invasive pneumococcal disease, and devising of immunization strategies that induce optimum immunogenicity and protection against invasive pneumococcal disease in the elderly have further promoted this surge in the BPS value.
Conversely, challenges linked with the accurate diagnosis of pneumococcal pneumonia will restrain the growth of pneumococcal testing market.
2015-2021 Pneumococcal Testing Market Demand Outlook Compared to 2022-2030 Forecast
Sales of pneumococcal testing grew at a CAGR of 9.8% between 2015 and 2021.
The pneumonia testing market is developing at a decent rate as pneumonia is a serious disease in which testing aids to detect the disease sooner and further, they can be treated rapidly. Furthermore, the awareness level is rising gradually which leads to early diagnosis, thus promoting the development of pneumonia testing market.
The main clinical syndromes of pneumococcal disease are meningitis, bacteremia, and pneumonia. According to the Centers for Diseases Control and Prevention in 2017, reports that 150,000 hospitalizations occurred from pneumococcal pneumonia yearly in the U.S. Pneumococci hold for about 30% of community-acquired pneumonia for adults. Bacteremia happens about 25–30% of pneumococcal pneumonia patients. The case-mortality rate is 5–7% and might be much higher amongst geriatric persons. This is expected to boost the demand for the market.
Considering this, FMI expects the global pneumococcal testing market to grow at a CAGR of 11.2% through 2030.
Which Factors Are Restraining Demand for Pneumococcal Testing?
The high cost of testing and limited reimbursement for new or expensive diagnostic tests are the primary factors hampering the pneumococcal testing market growth. Diagnostic tools for Legionella comprise antigen detection in urine, culture, immunohistochemistry or direct fluorescent antibody staining, serological testing, and polymerase chain reaction (PCR) testing.
Various commercially accessible urinary antigen tests for Legionella provide a quick diagnosis with high specificity. However, a 2016 study to evaluate the Legionella incidence and to understand the cost effectiveness of the test in Central Texas revealed that the projected cost of screening of population with Legionella urinary antigen testing was around $214,871.76 above 13 years, with a price per positive patient of $12,640.
Concerns and difficulties about reimbursement for expensive or new diagnostic tests may hinder innovation and are an important challenge to the market growth. Coverage for detection tests differs regionally, and given the absence of standards in determining coverage, this can present challenges for dissemination and development of a new diagnostic method.
Country-wise Insights
What Makes the U.S. a Large Market for Pneumococcal Testing?
The U.S. is estimated to account for around 82.9% of the North America pneumococcal testing market in 2022.
U.S. is anticipated to dominate the pneumonia testing market owing to increasing popularity among the healthcare industry for POC tests, increasing geriatric population, and increasing growth of advanced PCR-based technologies. For instance, as per the Centers for Disease Control and Prevention (CDC), pneumonia is an eighth primary cause for fatality in U.S. which further result into growth in awareness regarding the disease and further boosts the market.
Also, there are growing product approval and rising product launches that are boosting the overall market in the country. Moreover, with the growing healthcare expenditure and the availability of well-developed healthcare infrastructure is driving the growth of the market in U.S.
Why is Germany Considered a Lucrative Pneumococcal Testing Market?
Germany is estimated to account for 31.3% of the Europe pneumococcal testing market in 2022.
The development of the market in Germany is owing to the initiatives undertaken by the government regarding the growth of healthcare infrastructure, and availability of favorable regulations coupled with the high disease incidence levels in the country. Point-of-care testing is widely used in developed countries owing to high awareness as compared to the developing countries and improved reimbursement policies.
What are the Factors Fueling the Demand for Pneumococcal Testing in China?
The pneumococcal testing market in China is estimated to be worth US$ 42.6 Mn in 2022 in the global market.
The key factors fueling the development of the market include growing technological advancement in point-of-care diagnostics devices coupled with rising adoption of inorganic development strategies like agreements and collaborations to produce novel devices. This is projected to drive the market development in China. In addition, rising prevalence of pneumonia and the growing demand for its diagnosis via testing is another key factor adding to the development of the pneumococcal testing market in China.
How will the Pneumococcal Testing Market Expand across India?
Demand for pneumococcal testing in India is expected to rise at around 13.7% CAGR over the forecast period.
The rising elderly population and the rising awareness concerning pneumococcal testing are some of the key factors that will drive the market development in the country. The rising geriatric population is more susceptible to pneumonia which is growing the demand for pneumococcal testing.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCategory-wise Insights
Demand for Point of Care Testing to continue gaining Traction
By method, point of care testing is anticipated to hold the maximum share of 43.0% in 2022, expanding at rate of nearly 11.7% during the forecast period.
POC testing is an innovative technology that is presently an ideal technique for diagnosing pneumonia. The rising adoption of POC testing is owing to growing cases of pneumonia, higher efficiency of POC testing and the rapid test results, growing its preference over other testing methods.
Thus, with the increasing prevalence of chronic diseases and huge customer base adopting the inexpensive and instant diagnostic tests, is boosting the point of care testing. The benefits of POC test to render accurate and rapid results is also aiding in encouraging the patient-centered healthcare at home care settings which leads to adoption of point of care testing and thus encouraging the development of pneumonia testing market.
Why Analyzers will hold the most of the market share?
By Product, analyzers will lead the market and is projected to account for 59.7% of the total market revenue share in 2022.
The several advantages offered by analyzers is increasing the demand for analyzers thus increasing the market share of this segment. The advantages offered by analyzers include optimized time-consuming analytical and testing processes, reliable diagnostic information, accurate and timely analysis of samples and improved patient and wellness care.
Why Enzyme Linked Immunosorbent Assay (ELISA) contribute the highest market share by application?
In terms of technology, Enzyme Linked Immunosorbent Assay (ELISA) segment in projected to account for 29.7% of the total market share in 2022.
Immunofluorescence, even though, has been the traditional laboratory method in various biological applications, this technology is high-priced and requires trained professionals. ELISA (Enzyme linked immunosorbent assay) has evolved as a substitute method, as it offers high specificity and sensitivity, and is easier to carry out in comparison to other methods for diagnosis of substances in the body.
Why Hospitals projected maximum growth in the Pneumococcal Testing Market?
By end user, hospitals segment is anticipated to hold the maximum share of 55.3% in 2022, expanding at rapid rate of 11.5% CAGR during the forecast period.
The hospital segment is anticipated to dominate due to the higher implementation of advanced diagnostic equipment in hospitals. Also, trends like growing adoption of robotic technology and automation in instruments that enhances the results of diagnostic tests is projected to drive the segment. Moreover, favorable reimbursement policies for several diagnostic tests is also expected to support hospital segment retain its market share during the forecast period.
Competitive Landscape
Companies operating in the pneumococcal testing market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In January 2022, Quest Diagnostics announced that they will now offer consumer-initiated laboratory testing powered by QuestDirect™ in collaboration with Walmart. The new solution allows people to take control of their health care and purchase the same high quality laboratory tests ordered by healthcare providers through a consumer-friendly website. This collaboration builds upon a long-standing relationship between Walmart and Quest Diagnostics to broaden access to high quality health services.
- In December 2021, Quidel Corporation entered into a definitive agreement in which Quidel will acquire Ortho, one of the world’s largest in vitro diagnostics companies, for $24.68 per share of common stock using a combination of cash and newly issued shares in the combined company, representing a 25% premium over Ortho’s closing price and an equity value of approximately $6.0 billion.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2015-2021 |
|
Historical Data Available for |
2022-2030 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa, Northern Africa |
|
Key Segments Covered |
Method, Product, Technology, End User and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Pneumococcal Testing Market by Category
By Method:
- Immunodiagnostics
- Molecular Diagnostic
- Point of Care Testing
By Product:
- Consumables
- Analyzers
By Technology:
- Immunofluorescence
- Enzyme Linked Immunosorbent Assay (ELISA)
- Western Blot Test
- Nucleic Acid Sequence based Amplification
- Immunohistochemistry
- Polymerase Chain Reaction
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global pneumococcal testing market is worth US$ 1.4 Bn in 2021 and is set to expand 2.3X over the forecasted years owing to the rising cases of pneumonia, growing demand for pneumococcal testing and advancement in point-of-care testing for community-acquired pneumonia.
The sales of pneumococcal testing in the market have grown at a CAGR of nearly 9.8% between 2015 and 2021.
The pneumococcal testing market is expected to reach US$ 3.6 Bn by the end of 2030 with sales revenue expected to register CAGR of 11.2% over the forecast period.
North America holds the largest market share in the pneumococcal testing. North America currently is estimated to hold nearly 41.2% in 2022 of the global market share in pneumococcal testing market with U.S. being the leading contributor with a market value over US$ 532.9 Mn in 2022.
Demand of pneumococcal testing market is expected to register growth in Europe at rate of 12.2% CAGR during the forecast period.
The pneumococcal testing in China is likely to observe growth with an impressive CAGR of 10.5% during the forecast period. The key factors fueling the development of the market include growing technological advancement in point-of-care diagnostics devices coupled with rising adoption of inorganic development strategies like agreements and collaborations to produce novel devices.
Widespread adoption of nucleic acid detection tests (NATs), shift from centralized to decentralized point-of-care testing and shift from single-analyte testing to multiplex testing are key trends driving sales of pneumococcal testing market across the globe.
Japan’s pneumococcal testing market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 9.8% CAGR during the forecast period. South Korea market expected to exhibit healthy growth of 9.1% CAGR during the forecast period.
U.S., Germany, Canada, U.K. and France are the top 5 countries that are driving the demand for pneumococcal testing market.
Leading companies of pneumococcal testing market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Abbott Laboratories, F-Hoffmann la Roche Ltd, Hologic, Inc., bioMerieux, Bio-Rad Laboratories, Inc., Meridian Biosciences, Quest Diagnostics and Quidel.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, By Region
5. Market Background
5.1. COVID19 Crisis Analysis
5.1.1. Current COVID19 Statistics and Probable Future Impact
5.1.2. Current GDP Projection and Probable Impact
5.1.3. Current Economic Projection as compared to 2008 Economic analysis
5.1.4. COVID19 and Impact Analysis
5.1.4.1. Revenue By Method
5.1.4.2. Revenue By Type
5.1.4.3. Revenue By Technology
5.1.4.4. Revenue By End User
5.1.4.5. Revenue By Country
5.2. Macro-Economic Factors
5.2.1. Global GDP Growth Outlook
5.2.2. Global Healthcare Industry Market Outlook
5.2.3. Global Parent Market Outlook
5.3. Forecast Factors - Relevance & Impact
5.3.1. Rising demand of point of care testing
5.3.2. Increase in R&D Investment
5.3.3. Recent Advancement in Testing
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Trends
5.4.4. Opportunity Analysis
6. Global Pneumococcal Testing Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Method
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Method , 2015-2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method , 2022-2030
7.3.1. Immunodiagnostics
7.3.2. Molecular Diagnostics
7.3.3. Point-of-Care (POC) Testing
7.4. Market Attractiveness Analysis By Method
8. Global Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Type , 2022-2030
8.3.1. Consumables
8.3.2. Analysers
8.4. Market Attractiveness Analysis By Type
9. Global Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Technology, 2015-2021
9.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Technology, 2022-2030
9.3.1. Immunofluorescence
9.3.2. Enzyme Linked Immunosorbent Assay (ELISA)
9.3.3. Western Blot Test
9.3.4. Nucleic acid sequence-based amplification (NASBA)
9.3.5. Immunohistochemistry (IHC)
9.3.6. Polymerase Chain Reaction (PCR)
9.3.7. Others
9.4. Market Attractiveness Analysis By Technology
10. Global Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030
10.3.1. Hospitals
10.3.2. Diagnostics clinics
10.3.3. Home Care
10.3.4. Others
10.4. Market Attractiveness Analysis By End User
11. Global Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
12.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Method
12.3.3. By Product
12.3.4. By Technology
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
13.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Method
13.3.3. By Product
13.3.4. By Technology
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
14.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2022-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Method
14.3.3. By Product
14.3.4. By Technology
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
15.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy2022-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Method
15.3.3. By Product
15.3.4. By Technology
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
16.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Method
16.3.3. By Product
16.3.4. By Technology
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
17.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Method
17.3.3. By Product
17.3.4. By Technology
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2015-2021
18.3. Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Method
18.3.3. By Product
18.3.4. By Technology
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Emerging Countries Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
19.1. Introduction
19.1.1. Market Value (US$ Mn) and Volume (Units) Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Pneumococcal Testing Market Analysis
19.2.1. Introduction
19.2.2. Market Value (US$ Mn) and Volume (Units) Proportion Analysis by Market Taxonomy
19.2.2.1. By Method
19.2.2.2. By Product
19.2.2.3. By Technology
19.2.2.4. By End User
19.2.3. China Pneumococcal Testing Market - Competition Landscape
19.3. India Pneumococcal Testing Market Analysis
19.3.1. Introduction
19.3.2. Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
19.3.2.1. By Method
19.3.2.2. By Product
19.3.2.3. By Technology
19.3.2.4. By End User
19.3.3. India Pneumococcal Testing Market - Competition Landscape
19.4. Brazil Pneumococcal Testing Market Analysis
19.4.1. Introduction
19.4.2. Value (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy
19.4.2.1. By Method
19.4.2.2. By Product
19.4.2.3. By Technology
19.4.2.4. By End User
19.4.3. Brazil Pneumococcal Testing Market - Competition Landscape
20. Key Countries Pneumococcal Testing Market Analysis 2015-2021 and Forecast 2022-2030
20.1. U.S. Pneumococcal Testing Market Analysis
20.1.1. By Method
20.1.2. By Product
20.1.3. By Technology
20.2. Canada Pneumococcal Testing Market Analysis
20.2.1. By Method
20.2.2. By Product
20.2.3. By Technology
20.3. Mexico Pneumococcal Testing Market Analysis
20.3.1. By Method
20.3.2. By Product
20.3.3. By Technology
20.4. U.K. Pneumococcal Testing Market Analysis
20.4.1. By Method
20.4.2. By Product
20.4.3. By Technology
20.5. Germany Pneumococcal Testing Market Analysis
20.5.1. By Method
20.5.2. By Product
20.5.3. By Technology
20.6. France Pneumococcal Testing Market Analysis
20.6.1. By Method
20.6.2. By Product
20.6.3. By Technology
20.7. Italy Pneumococcal Testing Market Analysis
20.7.1. By Method
20.7.2. By Product
20.7.3. By Technology
20.8. Spain Pneumococcal Testing Market Analysis
20.8.1. By Method
20.8.2. By Product
20.8.3. By Technology
20.9. BENELUX Pneumococcal Testing Market Analysis
20.9.1. By Method
20.9.2. By Product
20.9.3. By Technology
20.10. Russia Pneumococcal Testing Market Analysis
20.10.1. By Method
20.10.2. By Product
20.10.3. By Technology
20.11. Japan Pneumococcal Testing Market Analysis
20.11.1. By Method
20.11.2. By Product
20.11.3. By Technology
20.12. South Korea Pneumococcal Testing Market Analysis
20.12.1. By Method
20.12.2. By Product
20.12.3. By Technology
20.13. Australia Pneumococcal Testing Market Analysis
20.13.1. By Method
20.13.2. By Product
20.13.3. By Technology
20.14. New Zealand Pneumococcal Testing Market Analysis
20.14.1. By Method
20.14.2. By Product
20.14.3. By Technology
20.15. GCC Countries Pneumococcal Testing Market Analysis
20.15.1. By Method
20.15.2. By Product
20.15.3. By Technology
20.16. Turkey Pneumococcal Testing Market Analysis
20.16.1. By Method
20.16.2. By Product
20.16.3. By Technology
20.17. South Africa Pneumococcal Testing Market Analysis
20.17.1. By Product
20.17.2. By Method
20.17.3. By Product
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1.1. Regional footprint of Players
21.4.1.2. Method foot print by Players
21.4.1.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Thermo Fisher Scientific Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Abbott Laboratories
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. F-Hoffmann la Roche Ltd.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. Hologic Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. bioMerieux
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Becton, Dickenson and Company
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Bio-Rad Laboratories Inc.
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. Meridian Biosciences
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Quest Diagnostics
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Quidel
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Drugs/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 02: Global Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 03: Global Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 04: Global Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 05: Global Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Region
Table 06: North America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 07: North America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 08: North America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 09: North America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 10: North America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 11: Latin America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 12: Latin America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 13: Latin America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 14: Latin America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 15: Latin America Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 16: Europe Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 17: Europe Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 18: Europe Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 19: Europe Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 20: Europe Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 21: South Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 22: South Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 23: South Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 24: South Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 25: South Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 26: East Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 27: East Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 28: East Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 29: East Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 30: East Asia Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 31: Oceania Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 32: Oceania Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 33: Oceania Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 34: Oceania Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 35: Oceania Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 36: Middle East and Africa Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 37: Middle East and Africa Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 38: Middle East and Africa Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 39: Middle East and Africa Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 40: Middle East and Africa Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Country
Table 41: China Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 42: China Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 43: China Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 44: China Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 45: India Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 46: India Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 47: India Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 48: India Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Table 49: Brazil Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Method
Table 50: Brazil Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Technology
Table 51: Brazil Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By Product
Table 52: Brazil Pneumococcal Testing Market Size (US$ Mn) Analysis 2015-2021 and Forecast 2022-2030, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 02: Global Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 03: Global Pneumococcal Testing Market Absolute $ Opportunity, 2021-2030
Figure 04: Global Pneumococcal Testing Market Share Analysis (%), By Method, 2022 & 2030
Figure 05: Global Pneumococcal Testing Market Y-o-Y Analysis (%), By Method, 2022-2030
Figure 06: Global Pneumococcal Testing Market Attractiveness Analysis by Method, 2022-2030
Figure 07: Global Pneumococcal Testing Market Share Analysis (%), By Technology, 2022 & 2030
Figure 08: Global Pneumococcal Testing Market Y-o-Y Analysis (%), By Technology, 2022-2030
Figure 09: Global Pneumococcal Testing Market Attractiveness Analysis by Technology, 2022-2030
Figure 10: Global Pneumococcal Testing Market Share Analysis (%), By Product, 2022 & 2030
Figure 11: Global Pneumococcal Testing Market Y-o-Y Analysis (%), By Product, 2022-2030
Figure 12 : Global Pneumococcal Testing Market Attractiveness Analysis by Product, 2022-2030
Figure 13: Global Pneumococcal Testing Market Share Analysis (%), By End User, 2022 & 2030
Figure 14: Global Pneumococcal Testing Market Y-o-Y Analysis (%), By End User, 2022-2030
Figure 15: Global Pneumococcal Testing Market Attractiveness Analysis by End User, 2022-2030
Figure 16: Global Pneumococcal Testing Market Share Analysis (%), By Region , 2022 & 2030
Figure 17: Global Pneumococcal Testing Market Y-o-Y Analysis (%), By Region , 2022-2030
Figure 18: Global Pneumococcal Testing Market Attractiveness Analysis by Region, 2022-2030
Figure 19: North America Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 20: North America Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 21: North America Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 22: North America Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 23: North America Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 24: North America Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 25: North America Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 26: North America Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 27: North America Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 28: North America Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 29: North America Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 30: North America Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 31: Latin America Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 32: Latin America Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 33: Latin America Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 34: Latin America Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 35: Latin America Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 36: Latin America Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 37: Latin America Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 38: Latin America Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 39: Latin America Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 40: Latin America Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 41: Latin America Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 42: Latin America Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 43: Europe Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 44: Europe Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 45: Europe Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 46: Europe Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 47: Europe Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 48: Europe Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 49: Europe Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 50: Europe Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 51: Europe Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 52: Europe Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 53: Europe Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 54: Europe Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 55: South Asia Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 56: South Asia Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 57: South Asia Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 58: South Asia Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 59: South Asia Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 60: South Asia Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 61: South Asia Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 62: South Asia Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 63: South Asia Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 64: South Asia Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 65: South Asia Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 66: South Asia Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 67: East Asia Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 68: East Asia Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 69: East Asia Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 70: East Asia Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 71: East Asia Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 72: East Asia Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 73: East Asia Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 74: East Asia Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 74: Emerging Countries Pneumococcal Testing Market Value (US$ Mn), By Key Countries, 2022-2030
Figure 75: East Asia Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 76: East Asia Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 77: East Asia Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 78: East Asia Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 79: Oceania Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 80: Oceania Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 81: Oceania Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 82: Oceania Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 83: Oceania Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 84: Oceania Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 85: Oceania Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 86: Oceania Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 87: Oceania Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 88: Oceania Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 89: Oceania Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 90: Oceania Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 91: Middle East and Africa Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 92: Middle East and Africa Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 93: Middle East and Africa Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 94: Middle East and Africa Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 95: Middle East and Africa Pneumococcal Testing Market Value Share By Country (2022 E)
Figure 96: Middle East and Africa Pneumococcal Testing Market Value Analysis (US$ Mn), 2015-2021
Figure 97: Middle East and Africa Pneumococcal Testing Market Value Forecast (US$ Mn), 2022-2030
Figure 98: Middle East and Africa Pneumococcal Testing Market Attractiveness Analysis, By Country
Figure 99: Middle East and Africa Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 100: Middle East and Africa Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 101: Middle East and Africa Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 102: Middle East and Africa Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 103: Emerging Countries Market Value Share (2021)
Figure 104: China Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 105: China Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 106: China Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 107: China Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 108: China Pneumococcal Testing Market Size (US$ Mn) Analysis, 2015-2021
Figure 109: China Pneumococcal Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2030
Figure 110: China Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 111: China Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 112: China Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 113: China Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 114: India Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 115: India Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 116: India Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 117: India Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 118: India Pneumococcal Testing Market Size (US$ Mn) Analysis, 2015-2021
Figure 119: India Pneumococcal Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2030
Figure 120: India Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 121: India Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 122: India Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 123: India Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 124: Brazil Pneumococcal Testing Market Value Share By Method (2022 E)
Figure 125: Brazil Pneumococcal Testing Market Value Share By Technology (2022 E)
Figure 126: Brazil Pneumococcal Testing Market Value Share By Product (2022 E)
Figure 127: Brazil Pneumococcal Testing Market Value Share By End User (2022 E)
Figure 128: Brazil Pneumococcal Testing Market Size (US$ Mn) Analysis, 2015-2021
Figure 129: Brazil Pneumococcal Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2030
Figure 130: Brazil Pneumococcal Testing Market Attractiveness Analysis, By Method
Figure 131: Brazil Pneumococcal Testing Market Attractiveness Analysis, By Technology
Figure 132: Brazil Pneumococcal Testing Market Attractiveness Analysis, By Product
Figure 133: Brazil Pneumococcal Testing Market Attractiveness Analysis, By End User
Figure 134: U.S Pneumococcal Testing Market Value Proportion Analysis
Figure 135: U.S. Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 136: U.S. Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 137: U.S. Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 138: Global Vs. U.S Growth Comparison
Figure 139: Canada Pneumococcal Testing Market Value Proportion Analysis
Figure 140: Canada Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 141: Canada Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 142: Canada Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 143: Global Vs. Canada Growth Comparison
Figure 144: Mexico Pneumococcal Testing Market Value Proportion Analysis
Figure 145: Mexico Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 146: Mexico Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 147: Mexico Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 148: Global Vs. Mexico Growth Comparison
Figure 149: U.K. Pneumococcal Testing Market Value Proportion Analysis
Figure 150: U.K. Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 151: U.K. Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 152: U.K. Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 153: Global Vs. U.K. Growth Comparison
Figure 154: Germany Pneumococcal Testing Market Value Proportion Analysis
Figure 155: Germany Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 156: Germany Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 157: Germany Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 158: Global Vs. Germany Growth Comparison
Figure 159: France Pneumococcal Testing Market Value Proportion Analysis
Figure 160: France Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 161: France Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 162: France Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 163: Global Vs. France Growth Comparison
Figure 164: Italy Pneumococcal Testing Market Value Proportion Analysis
Figure 165: Italy Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 166: Italy Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 167: Italy Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 168: Global Vs. Italy Growth Comparison
Figure 169: Spain Pneumococcal Testing Market Value Proportion Analysis
Figure 170: Spain Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 171: Spain Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 172: Spain Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 173: Global Vs. Spain Growth Comparison
Figure 174: BENELUX Pneumococcal Testing Market Value Proportion Analysis
Figure 175: BENELUX Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 176: BENELUX Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 177: BENELUX Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 178: Global Vs. BENELUX Growth Comparison
Figure 179: Russia Pneumococcal Testing Market Value Proportion Analysis
Figure 180: Russia Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 181: Russia Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 182: Russia Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 183: Global Vs. Russia Growth Comparison
Figure 184: Japan Pneumococcal Testing Market Value Proportion Analysis
Figure 185: Japan Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 186: Japan Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 187: Japan Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 188: Global Vs. Japan Growth Comparison
Figure 189: South Korea Pneumococcal Testing Market Value Proportion Analysis
Figure 190: South Korea Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 191: South Korea Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 192: South Korea Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 193: Global Vs. South Korea Growth Comparison
Figure 194: Australia Pneumococcal Testing Market Value Proportion Analysis
Figure 195: Australia Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 196: Australia Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 197: Australia Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 198: Global Vs. Australia Growth Comparison
Figure 199: New Zealand Pneumococcal Testing Market Value Proportion Analysis
Figure 200: New Zealand Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 201: New Zealand Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 202: New Zealand Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 203: Global Vs. New Zealand Growth Comparison
Figure 204: GCC Countries Pneumococcal Testing Market Value Proportion Analysis
Figure 205: GCC Countries Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 206: GCC Countries Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 207: GCC Countries Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 208: Global Vs. GCC Countries Growth Comparison
Figure 209: Turkey Pneumococcal Testing Market Value Proportion Analysis
Figure 210: Turkey Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 211: Turkey Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 212: Turkey Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 213: Global Vs. Turkey Growth Comparison
Figure 214: South Africa Pneumococcal Testing Market Value Proportion Analysis
Figure 215: South Africa Pneumococcal Testing Market Share Analysis (%) By Technology, 2022 & 2030
Figure 216: South Africa Pneumococcal Testing Market Share Analysis (%) By Method, 2022 & 2030
Figure 217: South Africa Pneumococcal Testing Market Share Analysis (%) By Product, 2022 & 2030
Figure 218: Global Vs. South Africa Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
